Unicycive Therapeutics, Inc, based in Los Altos, CA, is a biotech company dedicated to revolutionizing healthcare by providing game-changing solutions for underserved patients. With a unified mindset and a focus on major global health issues, such as kidney diseases, Unicycive aims to deliver disease-modifying therapies efficiently through their meticulously designed biotech system and end-to-end mining process.
One of their promising investigational drugs, UNI-494, targets acute kidney injury impairment by leveraging the potential of mitochondria. Additionally, their proprietary nanoparticle technology, Oxylanthanum Carbonate (OLC), shows therapeutic promise in hyperphosphatemia. Committed to making a meaningful difference in patients' lives, Unicycive provides resources and support to navigate renal diseases.
Generated from the website